Promising New Lyme Disease Vaccine in Clinical Trials

Published on October 18, 2021

There is promising news on the horizon for people living in areas where Lyme disease is common. Pfizer and Valneva, two pharmaceutical giants, are in Phase 2 trials to develop a vaccine that prevents Lyme disease. This potentially serious, systemic infection transmitted by…

Read Full Article (External Site)